Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 37 points (0.2%) at 17,115 as of Thursday, Sept. 4, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,639 issues advancing vs. 1,333 declining with 167 unchanged. The Health Care sector currently is unchanged today versus the S&P 500, which is up 0.2%. Top gainers within the sector include WellPoint ( WLP), up 1.6%, Cigna ( CI), up 1.3%, Aetna ( AET), up 0.9%, UnitedHealth Group ( UNH), up 0.9% and Thermo Fisher Scientific ( TMO), up 0.6%. On the negative front, top decliners within the sector include Universal Health Services ( UHS), down 4.4%, Jazz Pharmaceuticals ( JAZZ), down 3.6%, Tenet Healthcare ( THC), down 3.5%, Biomarin Pharmaceutical ( BMRN), down 2.8% and Novo Nordisk A/S ( NVO), down 2.0%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. Humana ( HUM) is one of the companies pushing the Health Care sector higher today. As of noon trading, Humana is up $1.04 (0.8%) to $128.29 on heavy volume. Thus far, 812,560 shares of Humana exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $127.33-$129.75 after having opened the day at $127.35 as compared to the previous trading day's close of $127.25. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in Retail, Employer Group, Healthcare Services, and Other Businesses segments. Humana has a market cap of $19.7 billion and is part of the health services industry. Shares are up 23.3% year-to-date as of the close of trading on Wednesday. Currently there are 10 analysts who rate Humana a buy, 1 analyst rates it a sell, and 8 rate it a hold. TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Humana Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.